-transparent.png){kind=logo}
IL-1 possesses pleiotropic properties on various cells and its activity may be stringently regulated in several ways. We have previously reported that both IL-1 and its inhibitory factor are concomitantly released from alveolar macrophages in both healthy subjects and patients with chronic inflammatory lung diseases. An increase in IL-1 activities and a decrease in inhibitory activities are characteristics found in both healthy smokers and patients with interstitial lung diseases. In this study, we further examined the biological properties of IL-1 inhibitory factor. The inhibitor exhibited a dose-dependent specific inhibition of an augmentation by IL-1 of PHA-induced murine thymocyte proliferation, while no inhibition of the augmentation by IL-2, IL-4, IL-6, or tumour necrosis factor (TNF) was found. 125I-labelled IL-1 alpha binding on PHA-stimulated murine thymocytes revealed two types of IL-1 binding sites, 44 sites/cell with a Kd of 2.7 x 10(-10) M and 230 sites/cell with a Kd of 2.5 x 10(-9) M. Alveolar macrophage culture supernatants blocked the binding of labelled IL-1 to the IL-1 receptor in a dose-dependent fashion. Scatchard plot analysis revealed that the inhibitory factor in the supernatants blocked the binding competitively. These results indicate that alveolar macrophages produce a specific IL-1 inhibitory factor, functioning as an IL-1 receptor antagonist.
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
October 1992,
Journal of applied physiology (Bethesda, Md. : 1985),
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
August 1993,
The American review of respiratory disease,
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
October 1987,
Nihon Kyobu Shikkan Gakkai zasshi,
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
February 2020,
Journal of immunology (Baltimore, Md. : 1950),
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
April 1994,
The European respiratory journal,
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
May 1994,
Annals of the New York Academy of Sciences,
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
May 1997,
Cytokine,
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
July 1988,
The American review of respiratory disease,
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
March 1997,
Journal of dermatological science,
M Takeuchi, and
S Nagai, and
H Nakada, and
H Aung, and
N Satake, and
H Kaneshima, and
T Izumi
November 1999,
Nihon rinsho. Japanese journal of clinical medicine,
